BOSTON SCIENTIFIC CORP (NYSE:BSX) stands out as a compelling candidate for investors following the Minervini trend-following strategy while also meeting high-growth investment criteria. The company, a leader in medical device innovation, demonstrates strong technical and fundamental characteristics that align with both momentum and growth investing principles.
Why BSX Fits the Minervini Trend Template
Mark Minervini’s strategy focuses on identifying stocks with strong uptrends and relative strength. BSX meets these criteria:
Price Above Key Moving Averages:
Current price ($104.58) is above the 50-day ($102.21), 150-day ($98.70), and 200-day ($95.34) moving averages.
The 50-day MA is above both the 150-day and 200-day MAs, confirming bullish momentum.
Upward-Trending Averages:
The 150-day and 200-day MAs are rising, reinforcing long-term strength.
Price Near 52-Week High:
BSX is trading within 2.4% of its 52-week high ($107.17), a sign of sustained momentum.
Strong Relative Strength:
With a ChartMill Relative Strength score of 83.36, BSX outperforms 83% of stocks in its sector.
High Growth Fundamentals
Beyond technical strength, BSX exhibits robust earnings and revenue growth:
Earnings Growth:
EPS (TTM) grew 26.2% YoY, with recent quarterly growth accelerating to 33.9%.
The company has beaten EPS estimates in all of the last four quarters, with an average beat of 7.1%.
Revenue Expansion:
Revenue (TTM) increased 19.4% YoY, with the latest quarter showing 20.9% growth.
Analysts have raised next-year EPS and revenue estimates by 2.1% and 1.7% over the past three months.
Improving Profit Margins:
Quarterly profit margins expanded from 7.9% to 14.5% over the past year, reflecting operational efficiency.
Technical Outlook
According to ChartMill’s technical report, BSX scores a perfect 10/10 on technical health, supported by:
A strong uptrend in both short and long-term timeframes.
Trading near 52-week highs with solid volume support.
Multiple support zones between $89.25 and $102.21, providing downside protection.
While the setup rating (6/10) suggests some volatility, the overall trend remains favorable for momentum investors.